ThinkSabio

$ABT

$98.75▲ +0.6% YTD

10 SEC 13D/G filings tracked · Last updated Oct 7, 2026

Filing History
News
ABT ▲ +0.6% - Abbott Laboratories
CP $98.75▲ +0.6%Oct 7, 2026 · ThinkSabio Blog

$ABT - Abbott introduces Ensure® Max Protein 3-in-1 Muscle Support, bringing the benefits of a supplement stack into one scoop…

News
ABT ▲ +0.1% - Abbott Laboratories
CP $97.65▲ +0.1%Oct 5, 2026 · ThinkSabio Blog

$ABT - Abbott receives FDA approval for new CardioMEMS HF System capabilities that help patients engage in the care of their heart condition…

News
ABT ▲ +1.5% - Abbott Laboratories
CP $98.00▲ +1.5%Oct 2, 2026 · ThinkSabio Blog

$ABT u/g Buy @ Rothschild pt 127 from 119…

News
ABT ▲ +0.0% - Abbott Laboratories
CP $101.00▲ +0.0%Sep 30, 2026 · ThinkSabio Blog

$ABT - Abbott hosts conference call for third-quarter earnings…

News
ABT ▲ +0.0% - Abbott Laboratories
CP $101.00▲ +0.0%Sep 30, 2026 · ThinkSabio Blog

$ABT - Abbott launches SimpleScreen™ CRC blood test, joining Cologuard Plus® in its colorectal cancer screening portfolio…

News
ABT ▲ +0.2% - Abbott Laboratories
CP $103.96▲ +0.2%Sep 23, 2026 · ThinkSabio Blog

$ABT - Abbott And Berry Street Partner To Expand Personalized Nutrition Support For Consumers Seeking Better Metabolic Health…

News
ABT ▼ -0.9% - Abbott Laboratories
CP $101.44▲ -0.9%Sep 17, 2026 · ThinkSabio Blog

$ABT - Abbott declares 411th consecutive quarterly dividend…

News
ABT ▲ +1.3% - Abbott Laboratories
CP $103.31▲ +1.3%Sep 14, 2026 · ThinkSabio Blog

$ABT - Abbott reaches agreement with Department of Justice to resolve claims relating to 2022 infant formula recall…

News
ABT ▼ -1.2% - Abbott Laboratories
CP $107.00▲ -1.2%Sep 8, 2026 · ThinkSabio Blog

$ABT - Abbott receives FDA approval for its TactiFlex™ Duo Ablation Catheter to treat people with abnormal heart rhythms…

News
ABT ▼ -0.3% - Abbott Laboratories
CP $112.12▲ -0.3%Aug 31, 2026 · ThinkSabio Blog

$ABT - Abbott launches the first and only ready-to-feed liquid infant formula made with whole milk in the U.S. at similar price to its existing Simila…